PlainRecalls
FDA Drug Low Class III Terminated

Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90

Reported: April 22, 2015 Initiated: March 26, 2015 #D-0488-2015

Product Description

Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90

Reason for Recall

Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell

Details

Units Affected
2,628 bottles
Distribution
Nationwide
Location
Davie, FL

Frequently Asked Questions

What product was recalled?
Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90. Recalled by Actavis Laboratories, FL, Inc.. Units affected: 2,628 bottles.
Why was this product recalled?
Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell
Which agency issued this recall?
This recall was issued by the FDA Drug on April 22, 2015. Severity: Low. Recall number: D-0488-2015.